• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病中铁沉积模式与组织学严重程度的关系。

Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

机构信息

Benaroya Research Institute, Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA, USA.

出版信息

Hepatology. 2011 Feb;53(2):448-57. doi: 10.1002/hep.24038. Epub 2010 Nov 29.

DOI:10.1002/hep.24038
PMID:21274866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3058264/
Abstract

UNLABELLED

Previous studies examining the relationship between hepatic iron deposition and histological severity in nonalcoholic fatty liver disease (NAFLD) have been inconclusive. The goal of this study was to examine the relationship between hepatic iron deposition and liver histology in 849 patients enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network. Hepatic iron staining was performed in a central laboratory, and the stains were scored for grade and cellular and parenchymal localization by a central pathology committee; the relationship between the grade and pattern of iron deposition and the clinical, laboratory, and histological variables was examined with univariate and multivariate analyses. Stainable hepatic iron was present in 293 of 849 patients (34.5%) in one of three histological patterns: a hepatocellular (HC) pattern [63/849 (7.4%)], a reticuloendothelial system (RES) cell pattern [91/849 (10.7%)], or a mixed RES/HC pattern [139/849 (16.4%)]. Patients with the RES iron-staining pattern were more likely to have advanced fibrosis compared to those with those with HC iron (P = 0.01). Patients with RES iron were also more likely to have advanced histological features such as fibrosis (P = 0.049), portal inflammation (P = 0.002), HC ballooning (P = 0.006), and definite nonalcoholic steatohepatitis (P = 0.007) compared to those with patients with HC or mixed iron patterns. The presence of RES iron (odds ratio = 1.60, 95% confidence interval = 1.10-2.33, P = 0.015) was independently associated with advanced hepatic fibrosis on multiple regression analysis after adjustments for age, gender, diabetes status, and body mass index.

CONCLUSION

The presence and pattern of hepatic iron deposition are associated with distinct histological features in patients with NAFLD and may have implications for pathophysiology and therapy.

摘要

未加标签

之前研究检查了非酒精性脂肪性肝病(NAFLD)中肝铁沉积与组织学严重程度之间的关系,但结果并不一致。本研究的目的是检查非酒精性脂肪性肝炎临床研究网络中 849 例患者的肝铁沉积与肝组织学之间的关系。在一个中心实验室进行肝铁染色,由一个中心病理学委员会对染色进行分级和细胞及实质定位评分;使用单变量和多变量分析检查铁沉积的分级和模式与临床、实验室和组织学变量之间的关系。在 849 例患者中有 293 例(34.5%)存在三种组织学模式之一的可染色肝铁:肝细胞(HC)模式[849 例中的 63 例(7.4%)]、网状内皮系统(RES)细胞模式[849 例中的 91 例(10.7%)]或混合 RES/HC 模式[849 例中的 139 例(16.4%)]。与具有 HC 铁染色模式的患者相比,具有 RES 铁染色模式的患者更有可能存在晚期纤维化(P=0.01)。与具有 HC 或混合铁模式的患者相比,具有 RES 铁的患者也更有可能具有晚期组织学特征,如纤维化(P=0.049)、门脉炎症(P=0.002)、HC 气球样变(P=0.006)和明确的非酒精性脂肪性肝炎(P=0.007)。多回归分析调整年龄、性别、糖尿病状态和体重指数后,RES 铁的存在(比值比=1.60,95%置信区间=1.10-2.33,P=0.015)与晚期肝纤维化独立相关。

结论

在 NAFLD 患者中,肝铁沉积的存在和模式与不同的组织学特征相关,可能对发病机制和治疗有影响。

相似文献

1
Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中铁沉积模式与组织学严重程度的关系。
Hepatology. 2011 Feb;53(2):448-57. doi: 10.1002/hep.24038. Epub 2010 Nov 29.
2
Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease.肝网状内皮系统细胞铁沉积与非酒精性脂肪性肝病中的细胞凋亡增加有关。
Hepatology. 2013 May;57(5):1806-13. doi: 10.1002/hep.26238. Epub 2013 Mar 14.
3
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.血清铁蛋白是非酒精性脂肪性肝病患者组织学严重程度和肝纤维化进展的独立预测因子。
Hepatology. 2012 Jan;55(1):77-85. doi: 10.1002/hep.24706. Epub 2011 Dec 6.
4
Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.非酒精性脂肪性肝病伴 C282Y HFE 基因突变患者血清 hepcidin 降低和实质铁含量增加。
Hepatology. 2012 Nov;56(5):1730-40. doi: 10.1002/hep.25856. Epub 2012 Sep 20.
5
Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.代谢综合征与非酒精性脂肪性肝病患儿肝组织学的关系。
Am J Gastroenterol. 2010 Sep;105(9):2093-102. doi: 10.1038/ajg.2010.152. Epub 2010 Apr 6.
6
[Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease].
Korean J Gastroenterol. 2006 Jun;47(6):432-9.
7
Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease.肝脂肪变类型、程度和区域性与儿童非酒精性脂肪性肝病组织学特征的关系。
J Pediatr Gastroenterol Nutr. 2011 Feb;52(2):190-7. doi: 10.1097/MPG.0b013e3181fb47d3.
8
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.非酒精性脂肪性肝病成人的临床、实验室和组织学关联。
Hepatology. 2010 Sep;52(3):913-24. doi: 10.1002/hep.23784.
9
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease.评估血清铁蛋白和肝铁与非酒精性脂肪性肝病严重程度的相关性。
Liver Int. 2019 Jul;39(7):1325-1334. doi: 10.1111/liv.14096. Epub 2019 Mar 27.
10
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的 HFE 基因型、实质铁积累和肝纤维化。
Gastroenterology. 2010 Mar;138(3):905-12. doi: 10.1053/j.gastro.2009.11.013. Epub 2009 Nov 18.

引用本文的文献

1
Serum metabolites characterize hepatic phenotypes and reveal shared pathways: results from population-based imaging.血清代谢物可表征肝脏表型并揭示共同途径:基于人群成像的结果
Mol Med. 2025 Jul 21;31(1):260. doi: 10.1186/s10020-025-01309-z.
2
The association of dietary nutrients consumption with hepatic steatosis and fibrosis from NHANES 2017-2020.2017 - 2020年美国国家健康与营养检查调查(NHANES)中膳食营养素摄入量与肝脂肪变性和肝纤维化的关联
Front Nutr. 2025 Jun 24;12:1510860. doi: 10.3389/fnut.2025.1510860. eCollection 2025.
3
Killing hepatocellular carcinoma in the NAFLD/NASH stage: a comprehensive perspective on targeting regulated cell death.在非酒精性脂肪性肝病/非酒精性脂肪性肝炎阶段杀死肝细胞癌:关于靶向程序性细胞死亡的全面观点
Cell Death Discov. 2025 Jun 19;11(1):281. doi: 10.1038/s41420-025-02558-x.
4
A clinical predictive score of high liver iron content in metabolic hyperferritinemia: a retrospective cohort pilot study.代谢性高铁蛋白血症中高肝脏铁含量的临床预测评分:一项回顾性队列先导研究。
BMC Gastroenterol. 2025 May 2;25(1):331. doi: 10.1186/s12876-025-03891-2.
5
Extracellular RNA mediates iron-induced toxicity and inflammatory signalling in hepatic cells.细胞外RNA介导肝细胞中铁诱导的毒性和炎症信号传导。
Toxicol Rep. 2025 Jun;14:102002. doi: 10.1016/j.toxrep.2025.102002.
6
The emerging role of E3 ubiquitin ligases and deubiquitinases in metabolic dysfunction-associated steatotic liver disease.E3泛素连接酶和去泛素化酶在代谢功能障碍相关脂肪性肝病中的新作用
J Transl Med. 2025 Mar 25;23(1):368. doi: 10.1186/s12967-025-06255-2.
7
From mechanisms to medicine: Ferroptosis as a Therapeutic target in liver disorders.从机制到医学:铁死亡作为肝脏疾病的治疗靶点
Cell Commun Signal. 2025 Mar 7;23(1):125. doi: 10.1186/s12964-025-02121-2.
8
-derived acetate activates the hepatic AMPK/SIRT1/PGC-1 axis to alleviate ferroptosis in metabolic-associated fatty liver disease.源自醋酸盐可激活肝脏中的AMPK/SIRT1/PGC-1轴,以减轻代谢相关脂肪性肝病中的铁死亡。
Acta Pharm Sin B. 2025 Jan;15(1):151-167. doi: 10.1016/j.apsb.2024.10.010. Epub 2024 Oct 28.
9
Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target.非酒精性脂肪性肝病中的铁代谢:一个有前景的治疗靶点。
Liver Res. 2022 Sep 19;6(4):203-213. doi: 10.1016/j.livres.2022.09.003. eCollection 2022 Dec.
10
Iron overload is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes.铁过载与2型糖尿病中代谢功能障碍相关脂肪性肝病密切相关。
Obesity (Silver Spring). 2025 Mar;33(3):490-499. doi: 10.1002/oby.24236. Epub 2025 Feb 6.

本文引用的文献

1
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.吡格列酮、维生素 E 或安慰剂治疗非酒精性脂肪性肝炎。
N Engl J Med. 2010 May 6;362(18):1675-85. doi: 10.1056/NEJMoa0907929. Epub 2010 Apr 28.
2
The role of iron in nonalcoholic fatty liver disease: the story continues.铁在非酒精性脂肪性肝病中的作用:故事仍在继续。
Gastroenterology. 2010 Mar;138(3):817-9. doi: 10.1053/j.gastro.2010.01.023. Epub 2010 Jan 28.
3
The role of iron in the pathophysiology and treatment of chronic hepatitis C.铁在慢性丙型肝炎病理生理学及治疗中的作用
Can J Gastroenterol. 2009 Dec;23(12):822-8. doi: 10.1155/2009/290383.
4
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的 HFE 基因型、实质铁积累和肝纤维化。
Gastroenterology. 2010 Mar;138(3):905-12. doi: 10.1053/j.gastro.2009.11.013. Epub 2009 Nov 18.
5
ER stress controls iron metabolism through induction of hepcidin.内质网应激通过诱导铁调素控制铁代谢。
Science. 2009 Aug 14;325(5942):877-80. doi: 10.1126/science.1176639.
6
Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression.遗传性血色素沉着症蛋白HFE与转铁蛋白受体2的相互作用是转铁蛋白诱导的铁调素表达所必需的。
Cell Metab. 2009 Mar;9(3):217-27. doi: 10.1016/j.cmet.2009.01.010.
7
Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.在非酒精性脂肪性肝炎基础上发生肝细胞癌的患者中肝脏铁过量。
J Hepatol. 2009 Feb;50(2):351-7. doi: 10.1016/j.jhep.2008.09.011. Epub 2008 Nov 14.
8
Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.人类非酒精性脂肪性肝病中铁蓄积的潜在机制。
Am J Clin Nutr. 2008 May;87(5):1374-83. doi: 10.1093/ajcn/87.5.1374.
9
Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病成年患者中脂肪变性分级和区域位置与脂肪性肝炎组织学特征的关系。
J Hepatol. 2008 May;48(5):829-34. doi: 10.1016/j.jhep.2008.01.016. Epub 2008 Feb 12.
10
The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.转铁蛋白受体调节铁调素表达的Hfe依赖性调控。
Cell Metab. 2008 Mar;7(3):205-14. doi: 10.1016/j.cmet.2007.11.016.